Languages: English and Spanish
Mercedes Martillo-Zapata is a focused, detailed-oriented and accomplished clinical research professional with over 14 years of experience facilitating the development and execution of essential clinical research programs across influential medical organizations. She possesses in-depth knowledge of rules and regulations, the IRB approval process with ample experience in research involving a wide range of Phase I-IV clinical trials, medical, biologics, cosmetics and investigational devices.
Currently working as the clinical research director for RCCA, her core responsibilities range from corroboration of daily routine affairs to any progress toward expanding research-related activities. She oversees clinical research operations, manages the Clinical Research Team, and develops and implements long-term research strategies to execute successful clinical trials.
Mercedes received a degree in aviation from the Flight Safety International Academy; in parallel, she was an active part of the National Health Association as a clinical certified medical assistant. Currently, she is part of The Society of Clinical Research Associates as a certified clinical research professional. Mercedes also acquired certification from the Association of Clinical Research Professionals as certified clinical research coordinator. She is currently pursuing her nursing degree, which will consolidate her grasp to new levels upon completion. Her educational experiences and background make her a perfect researcher.
In addition, Mercedes serves as a teaching assistant in the Clinical Research Program at the University of Chicago. Mercedes sits on the Content Board for the Association of Clinical Research Professionals, for which she reviews lecture preparation and answer keys, develops examinations from pattern to material, and ensures that all relevant material for the courses are timely. She also is fluent in English and Spanish.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.